Legal & General Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
17,461
+12,173
| +230% | +$83.8K | ﹤0.01% | 2631 |
|
|
2025
Q1 | $15.2K | Sell |
5,288
-1,232
| -19% | -$3.55K | ﹤0.01% | 3041 |
|
|
2024
Q4 | $30.6K | Hold |
6,520
| – | – | ﹤0.01% | 2880 |
|
|
2024
Q3 | $23.3K | Buy |
6,520
+520
| +9% | +$1.86K | ﹤0.01% | 2992 |
|
|
2024
Q2 | $37.3K | Buy |
+6,000
| New | +$37.3K | ﹤0.01% | 2834 |
|
|
2023
Q2 | – | Sell |
-9,496
| Closed | -$27.1K | – | 3447 |
|
|
2023
Q1 | $27.1K | Sell |
9,496
-4,429
| -32% | -$12.6K | ﹤0.01% | 2985 |
|
|
2022
Q4 | $101K | Buy |
13,925
+1,066
| +8% | +$7.76K | ﹤0.01% | 2814 |
|
|
2022
Q3 | $104K | Sell |
12,859
-4,460
| -26% | -$36.1K | ﹤0.01% | 2810 |
|
|
2022
Q2 | $85K | Buy |
17,319
+991
| +6% | +$4.86K | ﹤0.01% | 2897 |
|
|
2022
Q1 | $385K | Sell |
16,328
-1,930
| -11% | -$45.5K | ﹤0.01% | 2464 |
|
|
2021
Q4 | $323K | Buy |
18,258
+16,129
| +758% | +$285K | ﹤0.01% | 2545 |
|
|
2021
Q3 | $60K | Buy |
2,129
+364
| +21% | +$10.3K | ﹤0.01% | 2933 |
|
|
2021
Q2 | $18K | Sell |
1,765
-143
| -7% | -$1.46K | ﹤0.01% | 3326 |
|
|
2021
Q1 | $22K | Buy |
1,908
+334
| +21% | +$3.85K | ﹤0.01% | 3093 |
|
|
2020
Q4 | $18K | Hold |
1,574
| – | – | ﹤0.01% | 3132 |
|
|
2020
Q3 | $12K | Sell |
1,574
-470
| -23% | -$3.58K | ﹤0.01% | 3154 |
|
|
2020
Q2 | $37K | Buy |
2,044
+105
| +5% | +$1.9K | ﹤0.01% | 2815 |
|
|
2020
Q1 | $25K | Buy |
1,939
+911
| +89% | +$11.7K | ﹤0.01% | 2826 |
|
|
2019
Q4 | $17K | Buy |
1,028
+152
| +17% | +$2.51K | ﹤0.01% | 3219 |
|
|
2019
Q3 | $6K | Buy |
+876
| New | +$6K | ﹤0.01% | 3317 |
|